What is a common treatment regimen for Crohn's disease?

The treatment of Crohn's disease often involves a combination of therapies aimed at controlling inflammation and inducing remission. Corticosteroids are commonly used as they effectively reduce inflammation and are particularly useful during acute flare-ups of the disease. Infliximab, a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α), is also a cornerstone of treatment for moderate to severe Crohn's disease. This medication specifically helps to diminish the inflammatory response and is often used in patients who do not respond adequately to corticosteroids or those looking to avoid their long-term side effects.

Together, corticosteroids and infliximab are effective in managing symptoms, promoting remission, and improving the quality of life for those with Crohn's disease, making this combination a standard part of the therapeutic regimen.

While aminosalicylates and antibiotics can play a role in treating Crohn's disease, they are typically not the first-line treatment for the more severe manifestations of the condition. Immunosuppressants can also be part of the management plan, but they are commonly used in conjunction with corticosteroids or other biologic therapies rather than as standalone treatments. Dietary modifications are beneficial in managing symptoms but do not replace pharmacologic management for the inflammation associated with Cro